Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-03-01
|
| Series: | Dermatology and Therapy |
| Online Access: | https://doi.org/10.1007/s13555-024-01317-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|